Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for rifamycin S (compound)
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Liver Pharmacology and Xenobiotic Response Repertoire
- Identification of biomarkers distinguishing chemical contaminants using rat hepatocytes
- Livers of rat exposed to variety of hepatotoxic compounds
Most Relevant Literature
- Amycolatopsis mediterranei: A Sixty-Year Journey from Strain Isolation to Unlocking Its Potential of…
- Efficacy of rifapentine and other rifamycins against Coxiella burnetii in vitro.
- A Comparative Insight on the Newly Emerging Rifamycins: Rifametane, Rifalazil, TNP-2092 and TNP-2198…
- Kanglemycin A Can Overcome Rifamycin Resistance Caused by ADP-Ribosylation by Arr Protein.
- Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium a…
Most Relevant Clinical Trials
- Rifamycin in Minimal Hepatic Encephalopathy
- Evaluation of the Effects of Irrigation of the Extraction Socket With Rifamycine
- Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of…
- Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SI…
- Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicat…
